Ustekinumab for psoriatic arthritis.
Cuchacovich
Raquel S
RS
Section of Rheumatology, Department of Medicine, LSU Health Sciences Center, New Orleans, LA 70112, USA.
Espinoza
Luis R
LR
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D018592:Cross-Over Studies; D004311:Double-Blind Method; D006801:Humans; D011565:Psoriasis / Q000145:classification / Q000150:complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome; D000069549:Ustekinumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069549:Ustekinumab